Science Strategic Acquisition Equity Alpha Warrant Exp 20 Jan 2026 *W EXP 01/20/2026
Change company Symbol lookup
Select an option...
SSAAW Science Strategic Acquisition Equity Alpha Warrant Exp 20 Jan 2026 *W EXP 01/20/2026
WETF Wisdom Tree Investments Inc
CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
FR First Industrial Realty Trust Inc
PNI PIMCO New York Municipal Income Fund II
NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN
DG Dollar General Corp
SPCO Stephan Co
KEX Kirby Corp
GM General Motors Co
Go

Company profile

Science Strategic Acquisition Corp. Alpha is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus on sectors, including direct-to-consumer (D2C) brands, D2C services & marketplaces and mobile & social entertainment. It neither engages in any operations nor generates any revenues.

Closing Price
$0.0601
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0601
Day's Low
0.0598
Volume
(Average)
Volume:
9,205

10-day average volume:
21,085
9,205

LAWSUITS FILED AGAINST AMZN, OSCR and UL - Jakubowitz Law Pursues Shareholders Claims

10:50 am ET July 1, 2022 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / July 1, 2022 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Amazon.com, Inc. (NASDAQ:AMZN)

CONTACT JAKUBOWITZ ABOUT AMZN:

https://claimyourloss.com/securities/amazon-com-inc-loss-submission-form/?id=29484&from=1

Class Period : February 1, 2019 - April 5, 2022

Lead Plaintiff Deadline : July 5, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Amazon engaged in anticompetitive conduct in its private-label business practices, including giving Amazon products preference over those of its competitors and using third-party sellers' non-public data to compete with them; (ii) the foregoing exposed Amazon to a heightened risk of regulatory scrutiny and/or enforcement actions; (iii) Amazon's revenues derived from its private-label business were in part the product of impermissible conduct and thus unsustainable; and (iv) as a result, the defendants' public statements throughout the class period were materially false and/or misleading.

Oscar Health, Inc. (NYSE:OSCR)

CONTACT JAKUBOWITZ ABOUT OSCR:

https://claimyourloss.com/securities/oscar-health-inc-loss-submission-form/?id=29484&from=1

This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's March 2021 initial public offering.

Lead Plaintiff Deadline : July 11, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant SEP membership growth; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Unilever PLC (NYSE:UL)

CONTACT JAKUBOWITZ ABOUT UL:

https://claimyourloss.com/securities/unilever-plc-loss-submission-form/?id=29484&from=1

This lawsuit is on behalf of all persons who purchased or otherwise acquired Unilever American Depositary Receipts between September 2, 2020 and July 21, 2021, inclusive.

Lead Plaintiff Deadline : August 15, 2022

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: a) in July 2020, the board of Ben & Jerry's, one of Unilever's marquee brands, passed a resolution to end sales of its ice cream in "Occupied Palestinian Territory" ; and b) this boycott decision risked adverse governmental actions for violations of laws, executive orders, or resolutions aimed at discouraging boycotts, divestment, and sanctions of Israel adopted by 35 U.S. states.

Jakubowitz Law, Friday, July 1, 2022, Press release picture

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW

1140 Avenue of the Americas

9th Floor

New York, New York 10036

T: (212) 867-4490

F: (212) 537-5887

SOURCE : Jakubowitz Law





View source version on accesswire.com:

https://www.accesswire.com/707327/LAWSUITS-FILED-AGAINST-AMZN-OSCR-and-UL--Jakubowitz-Law-Pursues-Shareholders-Claims



comtex tracking

COMTEX_409533785/2457/2022-07-01T10:50:43

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.